KR920001768B1 - Process for preparing cromone carboxylate - Google Patents

Process for preparing cromone carboxylate Download PDF

Info

Publication number
KR920001768B1
KR920001768B1 KR1019890020204A KR890020204A KR920001768B1 KR 920001768 B1 KR920001768 B1 KR 920001768B1 KR 1019890020204 A KR1019890020204 A KR 1019890020204A KR 890020204 A KR890020204 A KR 890020204A KR 920001768 B1 KR920001768 B1 KR 920001768B1
Authority
KR
South Korea
Prior art keywords
carboxylate
reaction
hydrogen
chromone
acid
Prior art date
Application number
KR1019890020204A
Other languages
Korean (ko)
Other versions
KR910011828A (en
Inventor
김상호
안병구
박영환
박우신
Original Assignee
주식회사 코오롱
하기주
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 코오롱, 하기주 filed Critical 주식회사 코오롱
Priority to KR1019890020204A priority Critical patent/KR920001768B1/en
Publication of KR910011828A publication Critical patent/KR910011828A/en
Application granted granted Critical
Publication of KR920001768B1 publication Critical patent/KR920001768B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Abstract

A process for preparing chromone carboxylate of formula (I) comprises (a) halobenzene of formula (II) or its nuclear substd. derivs. with oxaloacetic acid of formula (III) or its salts in an organic solvent at 20-80 deg.C, and (b) cyclizing the obtd. intermediate of formula (IV) in the presence of an acid catalyst. In the formulas, X=Cl, Br or F; R1 and R2 each = H or C1-4 alkoxy or alkyl; M=H or Na; R'=H or C1-3 alkyl. Pref. the organic solvent is chloroform, benzene, dioxane or toluene.

Description

크로몬 카르복실레이트의 제조방법Method for preparing chromone carboxylate

본 발명은 크로몬 카르복실레이트의 제조방법에 관한 것으로서, 더욱 상세하게는, 핵치환 클로로벤젠과 옥살로아세트산의 에스테르 및 나트륨염을 반응시켜 중간체를 형성한 후 축합가수분해반응을 시킴으로써 얻어지는 크로몬 카르복실레이트의 제조방법에 관한 것이다.The present invention relates to a method for producing chromone carboxylate, and more particularly, chromone obtained by reacting a nucleosubstituted chlorobenzene with an ester of oxaloacetic acid and sodium salt to form an intermediate, followed by a condensation hydrolysis reaction. It relates to a method for producing a carboxylate.

일반적으로, 높은 비타민 P효능을 가지고 당뇨병 등 혈관 합병증 치료에 사용되는 크로몬 카르복실산 화합물은, 핵치환 2-히드록시아세토페논과 디알킬옥살레이트를 알칼리금속 촉매하에서 에테르, 디옥산 및 에탄올 등의 유기 용매에 투입하여 축합반응시킨 후, 계속적인 고리화반응 및 가수분해 반응을 진행시킴으로써 제조되어 지는 바, 다음과 같은 반응 메카니즘이 알려져 있다.In general, chromone carboxylic acid compounds having a high vitamin P potency and used for the treatment of vascular complications such as diabetes mellitus include nucleosubstituted 2-hydroxyacetophenone and dialkyloxalate under an alkali metal catalyst such as ether, dioxane and ethanol. It is prepared by carrying out the condensation reaction by adding to an organic solvent of, followed by a continuous cyclization reaction and a hydrolysis reaction. The following reaction mechanism is known.

Figure kpo00001
Figure kpo00001

Figure kpo00002
Figure kpo00002

윗 식에서, X는 할로겐 원자이다.Wherein X is a halogen atom.

즉, 살리실산 메틸에스테르와 케토술폭사이드 화합물을 반응시켜 β-케토술폭사이드 화합물을 형성시킨 후, 이것을 다시 글리옥살산 부틸에스테르와 반응시킴으로써 크로몬 카르복실산 화합물을 제조하는 것이다.That is, a chromone carboxylic acid compound is manufactured by reacting a salicylic acid methyl ester and a keto sulfoxide compound to form a (beta) -keto sulfoxide compound, and then reacting this with glyoxalic acid butyl ester again.

그러나, 상술한 바와 같은 종래의 제조방법에 따르면, 다량의 에톡시나트륨염을 사용해야 하고, 수분이 거의 없는 불활성 조건하에서 반응을 진행시켜야 하므로 공정상의어려움이 있으며, 출발물질인 2-히드록시아세토폐논의 가격이 비싸기 때문에 비경제적일 뿐만아니라, 반응시 부산물로 생성되는 수산화나트륨을 중화시키기 위해서는 고리화 반응시 다량의 염산이 필요하게 되므로 공정상의 어려움이 따랐다(반응 메카니즘 Ⅰ).However, according to the conventional manufacturing method as described above, a large amount of ethoxy sodium salt must be used, and the reaction must be carried out under inert conditions with little moisture. In addition to being expensive, the process was difficult because of the high price of hydrochloric acid in the cyclization reaction to neutralize the sodium hydroxide produced as a by-product (reaction mechanism I).

또한, 케토술폭사이드를 사용해야 하기 때문에 취급이 까다롭고, 반응시 이성체가 형성되어 이를 분리해야 하므로 번거로울 뿐만아니라, 수율이 저하된다고 하는 단점이 있었다.In addition, it is difficult to handle because ketosulfoxide must be used, and it is cumbersome because the isomers are formed and separated during the reaction, and the yield is reduced.

상기의 출발물질을 사용하여 크로모 카르복실산을 합성하는 공정은 가장 일반적으로 쓰이는 공정이나, 금속 촉매를 과량으로 사용해야 하는 제조공정상의 어려움이 있으며 불활성 조건, 출발물질의 고가 등 문제점이 있었다.The process of synthesizing chromo carboxylic acid using the starting material is the most commonly used process, there is a difficulty in the manufacturing process to use an excessive amount of a metal catalyst, there are problems such as inert conditions, high cost of the starting material.

이에 본 발명은 2-히드록시아세토페논을 출발물질로 사용하는 공정상의 단점을 극복하여 저렴한 클로로 벤젠을 출발물질로 사용함으로써 온화한 반응조건을 통해 크로몬 카르복실산 및 그 유도체를 제조하게 되므로 상술한 바와 같은 종래의 문제점을 해소시키고 고순도 및 고수율로 크로몬 카르복실산의 제조방법을 제공하는데 그 목적이 있다.Accordingly, the present invention overcomes the disadvantages of the process using 2-hydroxyacetophenone as a starting material, and thus uses chlorobenzene as a starting material to produce chromone carboxylic acid and its derivatives through mild reaction conditions. It is an object of the present invention to solve the conventional problems as described above and to provide a method for preparing chromone carboxylic acid with high purity and high yield.

이하 본 발명을 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.

본 발명은 다음 일반식(Ⅰ)의 할로벤젠 또는 그 핵치환 유도체와 다음 일반식(Ⅱ)의 옥살로아세트산 또는 그의 염을 유기 용매하에서 20 내지 80℃의 온도로 1차 반응시켜 다음 일반식(Ⅲ)의 중간체를 얻은 후, 이 중간체를 산촉매하에서 고리화반응시켜 되는 것임을 특징으로 하는 다음 일반식(Ⅳ)의 크로몬 카르복실레이트 화합물의 제조방법인 것이다.The present invention primarily reacts the halobenzenes of the following general formula (I) or its nuclear substituted derivatives with the oxaloacetic acid or its salts of the following general formula (II) at a temperature of 20 to 80 ° C in an organic solvent, After obtaining the intermediate of III), the intermediate is a method for producing a chromone carboxylate compound of the following general formula (IV) characterized in that the intermediate is subjected to a cyclization reaction under an acid catalyst.

Figure kpo00003
Figure kpo00003

윗 식에서 X는 Cl, Br 또는 F이고, R1과 R2는 수소이거나 탄소수가 1 내지 4의 알콕시 또는 알킬기이며, M은 수소 또는 나트륨이고, R'는 수소이거나 탄소수가 1 내지 3의 알킬기이다.Wherein X is Cl, Br or F, R 1 and R 2 are hydrogen or an alkoxy or alkyl group having 1 to 4 carbon atoms, M is hydrogen or sodium, and R 'is hydrogen or an alkyl group having 1 to 3 carbon atoms .

이와 같은 본 발명을 더욱 상세히 설명하면 다음과 같다.Referring to the present invention in more detail as follows.

본 발명은 상기 일반식(Ⅲ)의 할로벤젠 또는 그 핵치환 유도체와 상기 일반식(Ⅳ)의 옥살로 초산 에스테르 및 그 염을 클로로포름, 벤젠, 디옥산 및 톨루엔 등의 유기용매내에서 반응시켜 반응중간체를 형성시키는 것이다. 이때 반응온도는 상온 내지 80℃, 반응시간은 치환제의 종류에 따라 각각 다르나 대략 2 내지 5시간이 적당하다.The present invention is reacted by reacting the halobenzene of the general formula (III) or a nuclear substituted derivative thereof with the oxalo acetate ester of the general formula (IV) and salts thereof in an organic solvent such as chloroform, benzene, dioxane and toluene. To form an intermediate. At this time, the reaction temperature is from room temperature to 80 ℃, the reaction time varies depending on the type of the substituent, but approximately 2 to 5 hours is appropriate.

이렇게 하여 생성된 다음 일반식(Ⅴ)의 화합물을 추출 및 여과시켜 분리해낸 다음 100℃의 온도에서 산에 용해시킨 후, 10 내지 20시간 동안 가열하여 고리화반응시킴으로써 다음 일반식(Ⅵ)의 크로몬 카르복실레이트가 제조되게 된다. 여기서, 사용되는 산으로는 클로FH술폰산, 폴리포스포르산, 황산 등이 있으며, 바람직하게는, 무수상태의 반응조건하에서 반응시킨다.The compound of formula (V) thus produced was extracted, filtered and separated, dissolved in acid at a temperature of 100 ° C., and then heated and cyclized for 10 to 20 hours to produce the following formula (VI). The mon carboxylate is to be prepared. Here, the acid used includes chlor-FH sulfonic acid, polyphosphoric acid, sulfuric acid, and the like, and is preferably reacted under anhydrous reaction conditions.

Figure kpo00004
Figure kpo00004

윗 식에서 X는 Br, Cl 또는 F등의 할로겐 원소이고, R1과 R2는 수소이거나 탄소수가 1 내지 4의 알콕시 또는 알킬기이며, R'는 수소이거나 탄소수가 1 내지 3의 알킬기이고, M은 수소이거나 나트륨 등의 금속이며, 이때 상기 일반식(Ⅳ)의 화합물에서 에틸에스테르는 트란스와 시스중 어느 방향으로 위치하여도 좋다.Wherein X is a halogen element such as Br, Cl or F, R 1 and R 2 are hydrogen or an alkoxy or alkyl group having 1 to 4 carbon atoms, R 'is hydrogen or an alkyl group having 1 to 3 carbon atoms, and M is Hydrogen or a metal such as sodium, wherein the ethyl ester in the compound of formula (IV) may be located in either trans or cis.

반응이 완결되면 반응조내에 냉수를 첨가시키고, 반응용액을 에틸아세테이트 등의 유기용매로 추출시킨 후, 감압증류 및 건조시켜 크로몬 카르복실레이트를 얻게 된다.When the reaction is completed, cold water is added to the reaction tank, the reaction solution is extracted with an organic solvent such as ethyl acetate, and then distilled under reduced pressure and dried to obtain chromone carboxylate.

여기서 얻어진 크로몬 카르복실레이트를 물, 메탄올, 에탄올, 물과 메탄올 및 물과 에탄올의 혼합용매에서 수산화칼륨이나 수산화나트륨과 같은 염기를 사용하여 5 내지 90℃의 온도에서 3 내지 5시간 동안 가열시킨 후, 온도를 낮추고 산성화시켜, 이때 생성된 고체를 여과시킴으로써 크로몬 카르복실산을 얻을 수 있게 된다.The chromone carboxylate obtained here was heated at a temperature of 5 to 90 ° C. for 3 to 5 hours using a base such as potassium hydroxide or sodium hydroxide in a mixed solvent of water, methanol, ethanol, water and methanol, and water and ethanol. The temperature is then lowered and acidified, whereby the resulting solid can be filtered to obtain chromone carboxylic acid.

상술한 바와 같은 본 발명을 일련의 반응식으로 나타내면 다음과 같다.The present invention as described above is represented by a series of schemes as follows.

Figure kpo00005
Figure kpo00005

윗 식에서 R1과 R2는 수소이거나 탄소수가 1 내지 4의 알콕시가 또는 알킬기이고, R'는 수소이거나 탄소수 1 내지 3의 알콕시 또는 알킬기이며, X는 할로겐원자이고, M은 수소이거나 나트륨 등의 금속이며, 이때 상기 일반식(Ⅳ)의 화합물에서 에틸에스테르는 트란스와 시스중 어느 방향으로 위치하여도 좋다.Wherein R 1 and R 2 are hydrogen or an alkoxy or alkyl group having 1 to 4 carbon atoms, R ′ is hydrogen or an alkoxy or alkyl group having 1 to 3 carbon atoms, X is a halogen atom, M is hydrogen or sodium In this case, the ethyl ester in the compound of the general formula (IV) may be located in either of trans and cis.

본 발명에 의해 합성된 화합물은 고혈압 및 당뇨병 동의 혈관합병증 치료에 유효하며, 투여약물로는 나트륨염이나, 아민염을 형성시켜 경구투여하는 방법이 좋다. 특히 R1과 R2가 수소이며, 디에틸아민과 염을 형성시킬 경우에 치료약으로서 유용하다.The compound synthesized according to the present invention is effective for treating hypertension and diabetic sinus vascular complications, and the administration drug may be a method of orally administering sodium salt or amine salt. Especially when R <1> and R <2> are hydrogen and they form a salt with diethylamine, it is useful as a therapeutic agent.

본 발명의 방법을 종래의 방법과 비교해보면, 취급이 까다로운 알콕시 금속염을 다량으로 사용하는 공정상의 단점이 해결되고, 고가의 2-히드록시아세토페논 및 그 유도체를 출발물질로 사용하는 대신에 클로로벤젠 등과 같은 저렴한 화합물을 출발물질로 사용하게 되므로 경제성이 있으며, 반응시 부반응이 감소되고 형성되는 부산물이 소금등이므로 처리가 용이할 뿐만아니라, 고순도 및 고수율로 크로몬 카르복실산을 얻을 수 있다고 하는 잇점이 있다.Comparing the method of the present invention with the conventional method, the process disadvantage of using a large amount of difficult alkoxy metal salts is solved, and chlorobenzene instead of using expensive 2-hydroxyacetophenone and its derivatives as starting materials. It is economical because it uses inexpensive compounds as starting materials, and side reactions are reduced during the reaction, and the by-products formed are salts, so it is easy to process, and it is possible to obtain chromone carboxylic acid with high purity and high yield. There is an advantage.

이와 같은 본 발명을 실시예에 의거하여 더욱 상세히 설명하면 다음과 같다.The present invention will be described in more detail based on the following examples.

[실시예 1]Example 1

(가) 클로로벤젠 20g을 디옥산 500ml에 용해시킨 후, 여기에 디에틸에스테르 옥살로-아세트산 나트륨 35g을 적가시켜 80℃에서 3시간 동안 가열시켰다. 반응이 완결되면 물 200ml을 첨가하고 에테르로 추출시킨 다음, 황산마그네슘으로 수분을 제거시킨 후, 여과 및 감압증류하여 퓨마릭 에스테르화합물을 얻었다. 얻어진 퓨마릭 에스테르화합물을 폴리포르포르산 200g에 투입시킨 후, 100℃의 온도로 12시간 동안 가열 반응시켰다. 반응이 완료되면 반응 혼합액에 냉수로 첨가시킨 다음, 그 용액을 에틸아세테이트로 추출하여 유기층을 물로 세척시키고 황산마그네슘으로 건조시킨 후, 감압농축 및 건조시켜서 얻어진 유상의 크로몬 카르복실레이트를 에테르와 혼합시키고 0℃로 냉각하여 침상의 백색 결정을 얻었다(수율 85%).(A) 20 g of chlorobenzene was dissolved in 500 ml of dioxane, and 35 g of diethyl ester oxalo-acetate acetate was added dropwise thereto, followed by heating at 80 ° C. for 3 hours. When the reaction was completed, 200ml of water was added and extracted with ether, followed by removing water with magnesium sulfate, followed by filtration and distillation under reduced pressure to obtain a fumaric ester compound. The obtained fumaric ester compound was added to 200 g of poly formic acid, and then heated at a temperature of 100 ° C. for 12 hours. After the reaction was completed, the reaction mixture was added with cold water, the solution was extracted with ethyl acetate, the organic layer was washed with water, dried over magnesium sulfate, concentrated and dried under reduced pressure, and the oily chromo carboxylate was mixed with ether. After cooling to 0 ° C, needle-like white crystals were obtained (yield 85%).

(나) 상기 (가)단계에서 얻어진 크로몬 카르복실레이트 5g을 에탄올에 용해시킨 후, 2N 수산화나트륨 수용액에 10ml를 첨가시키고 80℃의 온도에서 3시간 동안 가열시켰다. 반응이 완결되면 반응 용액을 냉각시켜 산성화시키고, 생성된 고체는 여과 및 건조시켜 크로몬 카르복실산을 얻었다(수율 82%).(B) After dissolving 5 g of chromone carboxylate obtained in step (A) in ethanol, 10 ml of 2N aqueous sodium hydroxide solution was added and heated at a temperature of 80 ° C. for 3 hours. Upon completion of the reaction, the reaction solution was cooled to acidify and the resulting solid was filtered and dried to give chromone carboxylic acid (yield 82%).

ⅠR : νCOOH1735cm-1 ⅠR: ν COOH 1735cm -1

융점 : 262 내지 263℃Melting Point: 262 ~ 263 ℃

순도 : 99.0%(적정법 이용)Purity: 99.0% (by titration method)

[실시예 2 내지 4][Examples 2 to 4]

상기 실시예 1에서와 동일하게 실시하되, 다음 표 1에 나타낸 화합물을 사용하였고, 최종 크로몬 카르복실산의 수율 및 융점도 다음 표 1에 함께 나타내었다.In the same manner as in Example 1, the compound shown in Table 1 was used, and the yield and melting point of the final chromone carboxylic acid are also shown in Table 1 below.

[표 1]TABLE 1

Figure kpo00006
Figure kpo00006

Claims (2)

다음 일반식(Ⅰ)의 할로벤젠 또는 그 핵치환 유도체와 다음 일반식(Ⅱ)의 옥살로아세트산 또는 그의 염을 유기 용매하에서 20 내지 80℃의 온도로 1차 반응시켜 다음 일반식(Ⅲ)의 중간체를 얻은 후, 이 중간체를 산촉매하에서 고리화반응시켜 되는 것임을 특징으로 하는 다음 일반식(Ⅳ)의 크로몬 카르복실레이트 화합물의 제조방법.Next, a halobenzene of the general formula (I) or a nuclear substituted derivative thereof and the oxaloacetic acid or its salt of the following general formula (II) are first reacted at a temperature of 20 to 80 ° C. in an organic solvent to A method for producing a chromone carboxylate compound of the following general formula (IV), wherein the intermediate is subjected to a cyclization reaction under an acid catalyst after obtaining the intermediate.
Figure kpo00007
Figure kpo00007
윗 식에서 X는 Cl, Br 또는 F이고, R1과 R2는 수소이거나 탄소수가 1 내지 4의 알콕시 또는 알킬기이며, M은 수소 또는 나트륨이고, R'는 수소이거나 탄소수가 1 내지 3의 알킬이다.Wherein X is Cl, Br or F, R 1 and R 2 are hydrogen or an alkoxy or alkyl group having 1 to 4 carbon atoms, M is hydrogen or sodium, and R 'is hydrogen or alkyl having 1 to 3 carbon atoms .
제1항에 있어서, 유기 용매는 클로로포름, 벤젠, 디옥산 및 톨루엔인 것임을 특징으로 하는 크로몬 카르복실레이트의 제조방법.The method of claim 1, wherein the organic solvent is chloroform, benzene, dioxane and toluene.
KR1019890020204A 1989-12-29 1989-12-29 Process for preparing cromone carboxylate KR920001768B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890020204A KR920001768B1 (en) 1989-12-29 1989-12-29 Process for preparing cromone carboxylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019890020204A KR920001768B1 (en) 1989-12-29 1989-12-29 Process for preparing cromone carboxylate

Publications (2)

Publication Number Publication Date
KR910011828A KR910011828A (en) 1991-08-07
KR920001768B1 true KR920001768B1 (en) 1992-03-02

Family

ID=19294246

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890020204A KR920001768B1 (en) 1989-12-29 1989-12-29 Process for preparing cromone carboxylate

Country Status (1)

Country Link
KR (1) KR920001768B1 (en)

Also Published As

Publication number Publication date
KR910011828A (en) 1991-08-07

Similar Documents

Publication Publication Date Title
US5332857A (en) 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
KR920001768B1 (en) Process for preparing cromone carboxylate
EP0271275B1 (en) Trifluorohydroxyaromatic acid and preparation thereof
KR0141482B1 (en) Process for the preparation of o-carboxypyridyl and o-carboxyquinolylimidazolinones
FR2551063A1 (en) New 2,5-dimethylpyrroles, process for preparing them and their therapeutic use
JPH09268186A (en) Production of 4-chromanones
US4009172A (en) 2,3,3A,6,7,7A-Hexahydro-thieno[3,2-b]pyridin-(4H)5-ones
HU194857B (en) Process for production of 4-amin-6-fluor-cromane-4-carbonic acid and its 2/r/ methilesther
JP3264672B2 (en) α-Tocopherol-4-aminobenzoic acid ester compound and method for producing the same
KR870000584B1 (en) Process for preparing 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
US4891433A (en) Process for the preparation of dibenzothiepin derivative
JPS6155501B2 (en)
KR100699457B1 (en) Process for preparing dibenzothiepin derivatives and intermediates thereof
KR920005417B1 (en) Process for preparing of dibezothiepin derivative
HU193454B (en) Process for producing 3-phenyl-butyraldehyde derivatives
BG60580B1 (en) Method for the preparation of 2,2-dimethyl-5-(2,5-dimethylphenoxy)-pentanoic acid, intermediate compounds for its preparation and method for the preparation of the intermediate compounds
KR870000865B1 (en) Prpeparation process of substituted benzoic acid derivatives
KR0129115B1 (en) Process for preparation of 3-brumocamphor
US3962342A (en) Bromination process
KR920003898B1 (en) Process for preparing 3,4-dehydro-2-methyl-4-oxo-2h-1,2-benzothiazine-3-carboxy-1,1-deoxide
KR100448642B1 (en) Method for producing phenyl propionic acid derivatives from 2-phenylpropionic acid by simple processing steps with high yield and purity
KR920005381B1 (en) Process for the preparation of halo acetal compound
KR860000845B1 (en) Process for preparing chromore-2-carboxylic acid and salts thereof
KR970005309B1 (en) Process for the preparation of furobenzoisoxazole derivatives
JPH05148176A (en) Method for formylating 5-substituted benzene

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970303

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee